Elbasvir

10-025

Elbasvir

Elbasvir is a direct-acting antiviral drug that potently inhibits hepatitis C virus (HCV) non-structural protein 5A (NS5A). NS5A is essential for HCV RNA synthesis and viral assembly, and elbasvir inhibits the assembly of new viral replicase complexes when used at a concentration of 50 pM. It exhibits potent inhibitory activity against a broad range of HCV genotypes. Formulations containing elbasvir have been used alone and in combination with NS3/4A protease inhibitors in the treatment of HCV. Identified as a potential inhibitor of SARS-CoV-2, responsible for COVID-19.

757.3 €

510306

Elbasvir

375 €

HY-15789

Elbasvir

Elbasvir (MK-8742) is a hepatitis C virus nonstructural protein 5A (HCV NS5A) inhibitor with EC50s of 4, 3 and 3 nM against genotype 1a, 1b, and 2a, respectively.

649.42 €

CT90

RANGE V - PVC Elbow (90°) Ø 100mm

60.48 €

MBS584768-01mg

CD83, Human, mAb ELBE-1

1026.5 €

MBS584768-05mg

CD83, Human, mAb ELBE-1

2346.12 €